Last quarter (Q ), WPD Pharmaceuticals's total revenue was C$―, a decrease of -100.00% from the same quarter last year. In Q, WPD Pharmaceuticals's net income was C$-85.85K. See WPD Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 20	Dec 19	Jan 19	Jan 18
Total Revenue	-	-	C$ -537.79K	-	C$ 0.00	C$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	C$ -537.79K	-	-	-
Operating Expense	C$ 184.58K	C$ 2.36M	C$ 7.92M	C$ 13.18M	C$ 808.04K	C$ 422.87K
Operating Income	C$ -184.58K	C$ -2.36M	C$ 91.15K	C$ -13.18M	C$ -808.04K	C$ -422.87K
Net Non Operating Interest Income Expense	C$ -22.82K	C$ -167.52K	C$ -21.73K	C$ 60.66K	C$ -2.17K	C$ -46.11K
Other Income Expense	-	C$ -6.40M	C$ -866.35K	C$ 1.62M	C$ 30.77K	C$ 45.59K
Pretax Income	C$ -202.47K	C$ 3.86M	C$ -7.52M	C$ -11.61M	C$ -779.44K	C$ -423.38K
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	C$ -202.47K	C$ 3.86M	-	C$ -11.61M	C$ -779.44K	C$ -423.38K
Basic EPS	-	C$ 0.03	C$ -0.07	C$ -3.40	C$ -0.04	C$ -0.07
Diluted EPS	-	C$ 0.03	-	C$ -3.40	C$ -0.04	C$ -0.07
Basic Average Shares	C$ 340.31M	C$ 113.44M	C$ 113.13M	C$ 3.42M	C$ 21.42M	C$ 6.03M
Diluted Average Shares	C$ 340.31M	C$ 113.44M	-	C$ 3.42M	C$ 21.42M	C$ 6.03M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	C$ 8.77K	C$ 1.15K
Total Expenses	C$ 184.58K	C$ 2.36M	-	C$ -13.18M	C$ 808.04K	C$ 422.87K
Net Income From Continuing And Discontinued Operation	C$ -202.47K	C$ 3.86M	C$ -7.52M	C$ -11.61M	C$ -779.44K	C$ -423.38K
Normalized Income	C$ -148.81K	C$ -1.69M	C$ -5.46M	C$ -8.63M	C$ -791.04K	C$ -466.65K
Interest Expense	-	-	-	-	C$ 2.17K	C$ 46.11K
EBIT	C$ -179.65K	C$ 4.02M	C$ -7.50M	C$ -11.55M	C$ -777.26K	C$ -377.27K
EBITDA	C$ -176.14K	C$ 4.05M	C$ -7.11M	C$ -11.45M	C$ -777.26K	C$ -377.27K

Currency in CAD

WPD Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing